A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients

Journal of Substance Abuse Treatment
David A SmelsonMaureen Kaune

Abstract

Cocaine use causes an initial increase in dopamine and serotonin neurotransmission that is largely responsible for the pleasurable and reinforcing effects of the drug. Dysregulation of these neurotransmitters during withdrawal plays an important role in craving. Recent research has focused on the use of dopamine and serotonin antagonists early in recovery to reduce cocaine craving in both schizophrenic and non-schizophrenic cocaine dependent patients. This 2-week, double blind, placebo-controlled study compared risperidone vs. placebo in reducing cue-elicited cocaine craving. Thirty-four subjects with cocaine dependence were randomized to either risperidone or a placebo and underwent a weekly cue-exposure procedure. Although both groups had a reduction in craving over time, there were no significant differences among those treated with risperidone (n=19) compared to those taking a placebo (n=16) on the four craving dimensions. The results do not support the hypothesis that risperidone reduces cocaine craving among non-schizophrenic cocaine-dependent individuals.

References

Jan 1, 1992·Journal of Substance Abuse Treatment·A T McLellanM Argeriou
Mar 1, 1991·Journal of Clinical Psychology·J VorisP Sebastian
May 1, 1995·The American Journal of Psychiatry·S L SatelD S Charney
May 1, 1994·The American Journal of Psychiatry·M J AlbaneseA I Green
May 30, 1997·Annals of the New York Academy of Sciences·N D VolkowJ S Fowler
Nov 14, 1997·Biological Psychiatry·B A JohnsonC Clyde
Apr 2, 1998·The American Journal on Addictions·A RoyD A Smelson
Apr 4, 1998·European Journal of Pharmacology·W M Meil, M D Schechter
Apr 1, 1999·Journal of Clinical Psychology·D A SmelsonC Engelhart
Jan 19, 2000·Trends in Pharmacological Sciences·A R Childress, C P O'Brien
Jun 1, 2000·Journal of Clinical Psychopharmacology·J GrabowskiR Bailey
Jul 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·A Abi-DarghamM Laruelle
Dec 1, 2001·Journal of Substance Abuse Treatment·C A Dackis, C P O'Brien
Jan 5, 2002·Journal of Substance Abuse Treatment·K H LittrellC G Johnson
Jul 30, 2002·The Journal of Clinical Psychiatry·Lance P Longo
Dec 4, 2002·Psychiatric Services : a Journal of the American Psychiatric Association·David A SmelsonDouglas Ziedonis
May 17, 2003·The Journal of Clinical Investigation·Nora D VolkowGene-Jack Wang
May 22, 2003·Drug and Alcohol Dependence·Kyle M KampmanCharles P O'Brien

❮ Previous
Next ❯

Citations

Oct 25, 2011·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Tayfun I Uzbay
Jan 30, 2013·Journal of Substance Abuse Treatment·Yolanda AlvarezMagí Farré
Nov 18, 2009·Pharmacology & Therapeutics·Bianca Jupp, Andrew J Lawrence
Aug 18, 2009·Pharmacology & Therapeutics·Noushin Yahyavi-Firouz-Abadi, Ronald E See
Sep 24, 2008·Pharmacology, Biochemistry, and Behavior·Zhen-Yu RenLin Lu
Jun 30, 2006·Biological Psychiatry·Matthew W FeltensteinRonald E See
Mar 21, 2006·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Kevin F CaseyMarco Leyton
Nov 1, 2005·European Journal of Pharmacology·Ingmar H A FrankenWim van den Brink
Jan 22, 2013·Neuroscience and Biobehavioral Reviews·Marco Leyton, Paul Vezina
May 27, 2015·Current Treatment Options in Psychiatry·Matthew L BanksS Stevens Negus
Jun 11, 2014·Behavioural Brain Research·Adam D Pyszczynski, Timothy A Shahan
Jun 14, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Daniel I Brierley, Colin Davidson
Feb 16, 2015·Drug and Alcohol Dependence·Andre TappAndrew J Saxon
Jan 22, 2013·The International Journal of Neuropsychopharmacology·Miaojun LaiWenhua Zhou
Oct 12, 2007·The International Journal of Neuropsychopharmacology·Laurent KarilaJean Pierre Lépine
Sep 6, 2008·Progress in Brain Research·Marcy J Bubar, Kathryn A Cunningham
Mar 18, 2008·Journal of Clinical Psychopharmacology·Annette KennedyAndre Tapp
Sep 26, 2006·Journal of Psychiatric Practice·Mark J Albanese, Jesse J Suh
Mar 20, 2016·The Cochrane Database of Systematic Reviews·Blanca I IndaveLaura Amato

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here